Phase 4 Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are currently in hospital with a newly diagnosed diagnosis of type 1 diabetes.
- People whose parent or legal guardian is able to provide written consent to participate.
Who may not be able to join:
- People who have already received a flu vaccine during the current flu season.
- People who have a strong medical reason to receive a flu vaccine unrelated to diabetes.
- People with a severe allergy to eggs or who have had an allergic reaction to a flu vaccine in the past.
- People who are currently suspected of having a fever or an active infection.
- People with a known sensitivity or allergy to any ingredient in the Vaxigrip Tetra vaccine, including egg proteins (ovalbumin or chicken proteins), neomycin, formaldehyde, or octoxinol.
- People whose immune system is weakened, either due to a medical condition or as a result of medication, in a way that may reduce how well their body responds to vaccines.
- People whose parent or legal guardian is unable to provide informed consent.
- People under 7 years of age or aged 18 years or older.
- People who have previously taken part in the INVITED trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0046730895413
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in fasting residual β cell (C-peptide) function.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.